Previously, we reported an association between estrogen receptor-a (ERa) upregulation and detrimental effects of neonatal diethylstilbestrol (DES) exposure in the rat penis. The objective of this study was to employ the ERa knockout (ERaKO) mouse model to test the hypothesis that ERa mediates DES effects in the developing penis. ERaKO and wild-type C57BL/6 mice received oil or DES at a dose of 0.2 mg/pup per day (0.1 mg/kg) on alternate days from postnatal days 2 to 12. Fertility was tested at 80-240 days of age and tissues were examined at 96-255 days of age. DES caused malformation of the os penis, significant reductions in penile length, diameter, and weight, accumulation of fat cells in the corpora cavernosa penis, and significant reductions in weight of the bulbospongiosus and levator ani muscles in wild-type mice. Conversely, ERaKO mice treated with DES developed none of the above abnormalities. While nine out of ten male mice sired pups in the wild-type/control group, none did in the wildtype/DES group. ERaKO mice, despite normal penile development, are inherently infertile. Both plasma and intratesticular testosterone levels were unaltered in the DES-treated wild-type or DES-treated ERaKO mice when compared with controls, although testosterone concentration was much higher in the ERaKO mice. Hence, the resistance of ERaKO mice to developing penile abnormalities provides unequivocal evidence of an obligatory role for ERa in mediating the harmful effects of neonatal DES exposure in the developing penis.